Mark R Charbonneau
6PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 11, 2026
Targeted detection of microbes in synbiotic medical foods SBD111 and SBD121 to evaluate gut persistence: a randomised, open label trial.K J Miller, I M Wolff, L A Montes de Oca Valeriano
|Aug 16, 2022
Publisher Correction: Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study.Marja K Puurunen, Jerry Vockley, Shawn L Searle
|Jul 23, 2021
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study.Marja K Puurunen, Jerry Vockley, Shawn L Searle
|Jul 23, 2021
Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria.Mark R Charbonneau, William S Denney, Nicholas G Horvath
|May 15, 2021
Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip.M Tyler Nelson, Mark R Charbonneau, Heidi G Coia
|Apr 10, 2020
Developing a new class of engineered live bacterial therapeutics to treat human diseases.Mark R Charbonneau, Vincent M Isabella, Ning Li
Pageof 1
Frequent Collaborators
3 joint publications
Caroline B Kurtz
3 joint publications
William S Denney
2 joint publications
Marja K Puurunen
1 joint publications
K J Miller
1 joint publications
I M Wolff
1 joint publications
L A Montes de Oca Valeriano
1 joint publications
M J Soto-Giron
1 joint publications
S Jangi
1 joint publications
A E Ballok
1 joint publications
G V Toledo
